HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 1215

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  

LETTER TO EDITOR Table of Contents   
Year : 2009  |  Volume : 34  |  Issue : 2  |  Page : 166

XDR tuberculosis: A looming threat

Department of Medicine, University College of Medical Sciences, Delhi, India

Date of Submission04-Oct-2008
Date of Acceptance01-Dec-2008

Correspondence Address:
Vishal Sharma
Department of Medicine, University College of Medical Sciences, Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-0218.51215

Rights and Permissions


How to cite this article:
Sharma V, Aggarwal S. XDR tuberculosis: A looming threat. Indian J Community Med 2009;34:166

How to cite this URL:
Sharma V, Aggarwal S. XDR tuberculosis: A looming threat. Indian J Community Med [serial online] 2009 [cited 2021 Sep 17];34:166. Available from: https://www.ijcm.org.in/text.asp?2009/34/2/166/51215


Grover, et al. have reviewed the recent advances in drug resistant tuberculosis. [1] In this regard, it is important not to forget the recent threat of extensively drug resistant (XDR) tuberculosis that is resistant to isoniazid, rifampin, a fluoroquinolone, and any injectable drug (aminoglycosides or polypetides). [2] The cases of XDR have been reported from across the globe. It is also a cause of major concern in India. [3] This strain requires multiple second-line drugs for treatment and early reports indicated very high case fatality rates. This was probably due to concurrent HIV infection. [2] In this entire gloomy scenario, there is at least one silver lining from the recent report from Peru. In that report, individualized treatment of HIV-negative XDR cases yielded results comparable to MDR tuberculosis. [4] The importance for India lies in the fact that Peru, much like us, is a developing country.

The objective for us, however, is to prevent the emergence and transmission of such a strain. The most important risk factor implicated in the occurrence of XDR cases is inadequate or inappropriate management of tuberculosis. Hence, there is an urgent need to strengthen services of DOTS and DOTS-Plus under RNTCP. Only an efficient first-line therapy in the form of DOTS can stop XDR tuberculosis from being a major public health concern in the days to come.

   References Top

1.Grover GS, Takkar J. Recent advances in multi-drug-resistant tuberculosis and RNTCP. Indian J Community Med 2008;33:219-23.  Back to cited text no. 1    Medknow Journal
2.Madariaga MG, Lalloo UG, Swindells S. Extensively drug-resistant tuberculosis. Am J Med 2008;121:835-44.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Udwadia ZF, Jain S, Rodrigues C, Mehta A. XDR tuberculosis in India: what's in a name? Lancet Infect Dis 2007;7:441-2.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, et al . Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008;359:563-74.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]

This article has been cited by
1 Mortality and associated factors of patients with extensive drug-resistant tuberculosis: an emerging public health crisis in China
Chengli Bei,Manjiao Fu,Yao Zhang,Hebin Xie,Ke Yin,Yanke Liu,Li Zhang,Bangruan Xie,Fang Li,Hua Huang,Yuhong Liu,Li Yang,Jing Zhou
BMC Infectious Diseases. 2018; 18(1)
[Pubmed] | [DOI]


Print this article  Email this article


    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Article in PDF (97 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded351    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

  Sitemap | What's New | Feedback | Copyright and Disclaimer
  2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007